Table 1.
Characteristics of 8610 female patients more than 60 years of age who were included in the study
| Characteristic | Value |
|---|---|
| Age, yr, mean (SD) | 70.9 (7.2) |
| Age at start of menopause, yr, mean (SD) | 50.0 (4.2) |
| Weight, kg, mean (SD) | 65.8 (11.9) |
| Body mass index, mean (SD) | 26.6 (4.7) |
| Previous or current use of corticosteroids for ≥ 3 mo, % (no.) | 5.3 (446/8483) |
| History of clinical fracture after age 45 years, % (no.) | 27.8 (2391/8610) |
| Wrist | 13.1 (1129/8610) |
| Vertebra | 9.2 (796/8610) |
| Hip | 2.3 (200/8610) |
| Other | 7.4 (634/8610) |
| Finding on radiograph, % (no.) | |
| Vertebral fracture | 12.7 (973/7683) |
| Scoliosis | 23.1 (1753/7604) |
| Thoracic kyphosis | 24.2 (1836/7582) |
| Osteoporosis,* % (no.) | 45.7 (1938/4238) |
| ≥ 1 anti-osteoporosis agent,† % (no.) | 34.1 (2936/8610) |
Note: SD = standard deviation.
*
T score ≤ −2.5.
†
Bisphosphonate, parathyroid hormone, selective estrogen receptor modulator or strontium ranelate.